Corient Capital Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $671K | Hold |
3,199
| – | – | 0.05% | 278 |
|
|
2022
Q2 | $671K | Buy |
3,199
+416
| +15% | +$87.3K | 0.05% | 291 |
|
|
2022
Q1 | $675K | Buy |
2,783
+237
| +9% | +$57.5K | 0.04% | 326 |
|
|
2021
Q4 | $663K | Buy |
2,546
+7
| +0.3% | +$1.82K | 0.04% | 313 |
|
|
2021
Q3 | $669K | Buy |
2,539
+119
| +5% | +$31.4K | 0.05% | 294 |
|
|
2021
Q2 | $597K | Buy |
2,420
+228
| +10% | +$56.2K | 0.04% | 321 |
|
|
2021
Q1 | $426K | Buy |
2,192
+38
| +2% | +$7.39K | 0.04% | 353 |
|
|
2020
Q4 | $457K | Buy |
2,154
+148
| +7% | +$31.4K | 0.05% | 288 |
|
|
2020
Q3 | $344K | Sell |
2,006
-86
| -4% | -$14.7K | 0.04% | 313 |
|
|
2020
Q2 | $402K | Buy |
2,092
+197
| +10% | +$37.9K | 0.05% | 284 |
|
|
2020
Q1 | $279K | Buy |
+1,895
| New | +$279K | 0.04% | 306 |
|